Explore / Clinical trial
Clinical trial

PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder

Usona InstituteTerminatedStarted Jun 30, 202026 enrolledUnited StatesNCT04353921

Abstract

This is a Phase 2 double-blind, long-term observational follow-up study of participants from Study PSIL201. Participants providing informed consent were enrolled into this study and completed web surveys and telephone interviews conducted by one central site at the following time intervals: months 3 and 6 (± 7 days for each assessment) and months 10 and 12 (± 14 days for each assessment).

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinDepression

Keywords

Major Depressive Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.